34 results on '"Giacomelli R."'
Search Results
2. Interleukin‐9 over‐expression and T helper 9 polarization in systemic sclerosis patients
3. Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögrenʼs syndrome: a pilot study
4. The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Stillʼs disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis
5. Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics
6. Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients
7. Cardiovascular disease risk burden in primary Sjögrenʼs syndrome: results of a population-based multicentre cohort study
8. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome
9. Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18
10. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy
11. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres
12. The −670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis
13. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis
14. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells
15. Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion
16. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion
17. High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis
18. Impairment of Endothelial Cell Differentiation From Bone Marrow–Derived Mesenchymal Stem Cells: New Insight Into the Pathogenesis of Systemic Sclerosis
19. Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes
20. Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis
21. Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations
22. Microchimerism in Sjögren's syndrome
23. Circulating γ/δ T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization
24. European multicentre study to define disease activity criteria for systemic sclerosis. * II. Identification of disease activity variables and development of preliminary activity indexes
25. European multicentre study to define disease activity criteria for systemic sclerosis. * I. Clinical and epidemiological features of 290 patients from 19 centres
26. Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)
27. Familial scleroderma: Do environmental factors, genes and microchimerism share the same relevance?
28. Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis
29. Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters
30. Impaired Human Ovarian Follicular Fluid Complement Function in Hereditary Angioedema
31. Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients
32. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD)
33. CIRCULATING Vδ1 + T CELLS ARE ACTIVATED AND ACCUMULATE IN THE SKIN OF SYSTEMIC SCLEROSIS PATIENTS
34. Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.